Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Merit Medical Systems (MMSI) EBIT Margin (2016 - 2025)

Merit Medical Systems' EBIT Margin history spans 16 years, with the latest figure at 24.02% for Q4 2025.

  • For Q4 2025, EBIT Margin fell 3432.0% year-over-year to 24.02%; the TTM value through Dec 2025 reached 2.37%, down 911.0%, while the annual FY2025 figure was 2.37%, 911.0% down from the prior year.
  • EBIT Margin for Q4 2025 was 24.02% at Merit Medical Systems, down from 11.09% in the prior quarter.
  • Across five years, EBIT Margin topped out at 13.59% in Q2 2024 and bottomed at 24.02% in Q4 2025.
  • The 5-year median for EBIT Margin is 8.38% (2022), against an average of 3.83%.
  • The largest annual shift saw EBIT Margin skyrocketed 3088bps in 2024 before it crashed -3432bps in 2025.
  • A 5-year view of EBIT Margin shows it stood at 9.95% in 2021, then plummeted by -36bps to 13.56% in 2022, then crashed by -52bps to 20.58% in 2023, then soared by 150bps to 10.3% in 2024, then plummeted by -333bps to 24.02% in 2025.
  • Per Business Quant, the three most recent readings for MMSI's EBIT Margin are 24.02% (Q4 2025), 11.09% (Q3 2025), and 12.26% (Q2 2025).